Quantcast

Latest Ramius LLC Stories

2011-02-24 09:14:00

NEW YORK, Feb. 24, 2011 /PRNewswire/ -- Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that Institutional Shareholder Services (ISS), the leading independent proxy voting advisory and risk management consulting firm to the global financial community, has recommended that shareholders of Zoran Corporation (Nasdaq: ZRAN) consent on Ramius' WHITE card to remove three incumbent directors and elect Ramius nominees Jon Castor,...

2011-02-11 08:36:00

NEW YORK, Feb. 11, 2011 /PRNewswire/ -- Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced it has filed supplemental presentation materials with the Securities and Exchange Commission ("SEC") and issued a statement to shareholders of Zoran Corporation (Nasdaq: ZRAN) condemning the Zoran Board of Directors for leading a campaign of misleading information designed to confuse and mislead shareholders. In the presentation...

2011-01-06 07:00:00

SAN DIEGO and NEW YORK, Jan. 6, 2011 /PRNewswire/ -- Ramius V&O Acquisition LLC ("V&O Acquisition"), affiliates of Ramius LLC (collectively, "Ramius") and affiliates of Royalty Pharma (together with Ramius and Purchaser, the "Ramius/RP Group") announced today that V&O Acquisition has successfully completed its cash tender offer to purchase all of the outstanding shares of Cypress Bioscience, Inc. (Nasdaq: CYPB) ("Cypress") not already owned by it or its subsidiaries for $6.50...

2010-12-21 07:45:00

SAN DIEGO and NEW YORK, Dec. 21, 2010 /PRNewswire/ -- Ramius V&O Acquisition LLC ("Purchaser"), affiliates of Ramius LLC (collectively, "Ramius") and affiliates of Royalty Pharma (together with Ramius and Purchaser, the "Ramius/RP Group") announced today that the Ramius/RP Group is extending its previously announced tender offer to acquire all of the outstanding shares of common stock of Cypress Bioscience, Inc. (Nasdaq: CYPB) ("Cypress"), a pharmaceutical company engaged in the...

2010-12-10 08:29:00

NEW YORK, Dec. 10, 2010 /PRNewswire/ -- Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that it has sent a letter to the Board of Directors of Cypress Bioscience, Inc. (Nasdaq: CYPB) outlining its willingness to acquire all of Cypress' outstanding Common Stock in a negotiated transaction for $5.50 per share. The offer is conditioned upon Cypress commencing exclusive negotiations with Ramius no later than Friday, December 10, 2010 and...

2010-12-06 07:19:00

NEW YORK, Dec. 6, 2010 /PRNewswire/ -- Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), announced today that it delivered a letter to Levy Gerzberg, the President and CEO of Zoran Corporation (Nasdaq: ZRAN), and to the members of Zoran's Board of Directors. Ramius is one of the largest shareholders of Zoran, beneficially owning approximately 8.3% of the shares outstanding. In the letter, Ramius stated it believes that Zoran's shares are...

2010-11-17 07:23:00

NEW YORK, Nov. 17, 2010 /PRNewswire/ -- Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today reported a 12% ownership stake in SurModics, Inc. (the "Company") (Nasdaq: SRDX) and disclosed that it delivered a letter to the SurModics Board of Directors. In the letter, Ramius cites the long-term underperformance of the Company's business and stock price. Ramius also announced today it has nominated three highly qualified director nominees...

2010-10-14 15:05:00

SANTA CLARA, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Extreme Networks, Inc. (Nasdaq: EXTR) and Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (together with its affiliates, "Ramius"), announced today that they have reached a settlement agreement related to the Company's 2010 annual meeting of stockholders. Under the terms of the settlement agreement, the Board has been increased from eight to nine members, and the Company and Ramius have agreed to a process by...

2010-09-21 10:24:00

NEW YORK, Sept. 21 /PRNewswire/ -- Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, "Ramius"), today announced that Cypress Bioscience, Inc. (Nasdaq: CYPB) has denied Ramius' legitimate request for a list of the Company's stockholders. Ramius owns 9.9% of the outstanding shares and has launched a tender offer to purchase all of the shares it does not currently own for $4.25 per share in cash. Ramius requested the stockholder list materials in...

2010-09-15 15:15:00

SANTA CLARA, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Aviat Networks, Inc. ("Aviat," Nasdaq: AVNW), a leading wireless expert in advanced IP network migration, today announced that it has reached a settlement agreement with Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (together with its affiliates, "Ramius"). Under the terms of the settlement agreement, Aviat Networks will include one candidate recommended by Ramius as a nominee on management's slate for...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.